Great set of figures.
My favourite line:
" Kit sales to customers in EMEA grew by more than 70% relative to 4Q FY20 and represented
more than 15% of 1Q FY21 revenue. The Company signed a new distributor in Greece, where
the number of active cases and tests performed each day has rapidly increased since August
2020."
Cant recall precisely but pretty sure that late last year EMEA was around 4% of overall sales, June this year was 9%. When one considers the growth in overall sales, the growth in this area is very promising.
News: GSS Genetic Signatures Says Quarterly Revenue $10.5 Mln, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.36M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.5¢ | $93.63K | 271.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 4501 | 1 |
View Market Depth
| Last trade - 15.03pm 25/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |